316 related articles for article (PubMed ID: 7884826)
21. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
Sutton MA; Freund CT; Berkman SA; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Lerner SP
Mol Ther; 2000 Sep; 2(3):211-7. PubMed ID: 10985951
[TBL] [Abstract][Full Text] [Related]
22. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration.
Tong XW; Block A; Chen SH; Contant CF; Agoulnik I; Blankenburg K; Kaufman RH; Woo SL; Kieback DG
Gynecol Oncol; 1996 May; 61(2):175-9. PubMed ID: 8626129
[TBL] [Abstract][Full Text] [Related]
23. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
[TBL] [Abstract][Full Text] [Related]
24. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
25. [Animal experiment on gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration in vivo].
Tong X; Sei W; Gu M
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):712-4. PubMed ID: 9772431
[TBL] [Abstract][Full Text] [Related]
26. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
[TBL] [Abstract][Full Text] [Related]
27. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
[TBL] [Abstract][Full Text] [Related]
28. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.
Freund CT; Tong XW; Block A; Contant CF; Kieback DG; Rowley DR; Lerner SP
Anticancer Res; 2000; 20(5A):2811-6. PubMed ID: 11062688
[TBL] [Abstract][Full Text] [Related]
31. Adenoviral-mediated suicide gene therapy for hepatic metastases of breast cancer.
Kwong YL; Chen SH; Kosai K; Finegold MJ; Woo SL
Cancer Gene Ther; 1996; 3(5):339-44. PubMed ID: 8894253
[TBL] [Abstract][Full Text] [Related]
32. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
33. Thymidine kinase-mediated killing of rat brain tumors.
Barba D; Hardin J; Ray J; Gage FH
J Neurosurg; 1993 Nov; 79(5):729-35. PubMed ID: 8410252
[TBL] [Abstract][Full Text] [Related]
34. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
[TBL] [Abstract][Full Text] [Related]
35. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
36. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
[TBL] [Abstract][Full Text] [Related]
38. [Antitumor gene therapy using suicide genes].
Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
Medicina (B Aires); 1998; 58(2):185-8. PubMed ID: 9706253
[TBL] [Abstract][Full Text] [Related]
39. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
40. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
